MRKR logo

Marker Therapeutics Stock Price

Symbol: NasdaqCM:MRKRMarket Cap: US$14.1mCategory: Pharmaceuticals & Biotech

MRKR Share Price Performance

US$1.21
-2.58 (-68.07%)
US$1.21
-2.58 (-68.07%)
Price US$1.21

MRKR Community Narratives

There are no narratives available yet.

Recent MRKR News & Updates

No updates

Marker Therapeutics, Inc. Key Details

US$5.7m

Revenue

US$14.0m

Cost of Revenue

-US$8.3m

Gross Profit

US$4.5m

Other Expenses

-US$12.8m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.13
Gross Margin
-146.28%
Net Profit Margin
-224.45%
Debt/Equity Ratio
0%

Marker Therapeutics, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About MRKR

Founded
n/a
Employees
5
CEO
Juan Vera
WebsiteView website
markertherapeutics.com

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

U.S. Market Performance

  • 7 Days: -0.2%
  • 3 Months: 12.2%
  • 1 Year: 22.4%
  • Year to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. Meanwhile, the market is actually up 22% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading